Product Description
Semax has shown strong potential in improving attention, learning capacity, and working memory. By elevating BDNF and other neurotrophic factors, it enhances neuroplasticity and supports long-term cognitive health.
Research demonstrates that Semax can reduce oxidative stress, minimize neuronal damage, and provide protection in ischemic and hypoxic models. Its neuroprotective capabilities make it valuable for studying brain injury, stroke models, and neurodegeneration.
Semax may help optimize cerebral circulation and energy metabolism by supporting mitochondrial function and enhancing oxygen delivery to brain tissues, contributing to faster recovery and better neurological performance.
Preclinical studies suggest that Semax exhibits anti-anxiety and antidepressant-like effects by regulating neurotransmitter systems involved in stress adaptation, offering potential applications in mood disorder research.
Semax is widely recognized for its favorable safety profile in research settings, demonstrating minimal toxicity even under extended study conditions.
| Parameter | Description |
| CAS Number | 80714-61-0 |
| Product Name | Semax |
| Molecular Formula | C₃₇H₅₁N₉O₁₀ |
| Molecular Weight | 813.86 g/mol |
| Amino Acid Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at –20°C, protected from light |
| Specification | Option |
| Purity | ≥98% (HPLC) |
| Form | Lyophilized powder |
| Vial Sizes | 1 mg, 5 mg, 10 mg, 50 mg (custom options available) |
| Packaging | Sterile sealed vials; moisture-resistant, temperature-controlled packaging |
| Shelf Life | 24 months under recommended storage conditions |
Semax is extensively studied for its potential to improve memory, learning, and neural adaptability, making it a key molecule for exploring nootropic mechanisms and synaptic plasticity.
Its ability to reduce neuronal damage and support neural regeneration positions Semax as a promising candidate for research on stroke models, traumatic brain injury (TBI), and ischemic conditions.
Semax’s influence on BDNF, oxidative stress reduction, and neurotransmitter modulation provides valuable insights for studying Alzheimer’s disease, Parkinson’s disease, and other age-related cognitive disorders.
Researchers utilize Semax in models investigating anxiety, depression, and stress-related neurological pathways due to its neuromodulatory effects.
Semax is a valuable compound in experimental formulations aimed at enhancing neuroprotection, cognitive enhancement, and targeted drug delivery for neurological applications.
